Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antiviral
Biotech
Poseida makes case for safety of Roche-partnered nonviral CAR-T
Poseida is showcasing data for a Roche-partnered candidate that uses a nonviral approach and could therefore offer a better CAR-T safety profile.
Gabrielle Masson
Dec 10, 2023 12:00pm
Pneumagen's flu antiviral stands up to human challenge study
Oct 2, 2023 4:00am
Potential for broad-spectrum antivirals could lie in host cells
Oct 12, 2022 12:21pm
Philanthropist puts up $171M to create pandemic antiviral center
Aug 31, 2022 9:45am
Enanta sinks to multiyear low as phase 2b RSV trial flames out
May 19, 2022 8:47am
How the test-to-treat pillar of the US COVID strategy is failing
Apr 15, 2022 2:50pm